Ian D. Dang

Array ( [id] => 9015629 [patent_doc_number] => 20130230593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'Orally Dosed Pharmaceutical Compositions Comprising a Delivery Agent in Micronized Form' [patent_app_type] => utility [patent_app_number] => 13/862811 [patent_app_country] => US [patent_app_date] => 2013-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5148 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9483070 [patent_doc_number] => 08729018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Therapeutic agents comprising elastic peptides' [patent_app_type] => utility [patent_app_number] => 13/796001 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 23 [patent_no_of_words] => 70845 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13796001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299642 [patent_doc_number] => 08647866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'ZCYTOR17 heterodimeric cytokine receptor polynucleotides' [patent_app_type] => utility [patent_app_number] => 13/741036 [patent_app_country] => US [patent_app_date] => 2013-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 85882 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13741036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586845 [patent_doc_number] => 20130005664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'THERAPEUTIC AGENTS COMPRISING ELASTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/612126 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 70282 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13612126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745388 [patent_doc_number] => 20130085104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/524807 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 68905 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13524807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8510286 [patent_doc_number] => 20120309694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'Dual Chain Synthetic Heparin-Binding Growth Factor Analogs' [patent_app_type] => utility [patent_app_number] => 13/454933 [patent_app_country] => US [patent_app_date] => 2012-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13310 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807782 [patent_doc_number] => 08445434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'IGF-1 fusion polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 13/416481 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10027 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13416481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312621 [patent_doc_number] => 20120189643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'Toll Like Receptor 3 Antagonists, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 13/412259 [patent_app_country] => US [patent_app_date] => 2012-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 19941 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13412259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453221 [patent_doc_number] => 20120264168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'ZCYTOR17 HETERODIMERIC CYTOKINE RECEPTOR POLYNUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/405916 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 85876 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13405916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239910 [patent_doc_number] => 20120148649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'COMPOSITION FOR RESTORATION OF AGE RELATED TISSUE IN THE FACE OR SELECTED AREAS OF THE BODY' [patent_app_type] => utility [patent_app_number] => 13/403473 [patent_app_country] => US [patent_app_date] => 2012-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5165 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13403473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312560 [patent_doc_number] => 20120189577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'USE OF IL-12 TO INCREASE SURVIVAL FOLLOWING ACUTE EXPOSURE TO IONIZING RADIATION' [patent_app_type] => utility [patent_app_number] => 13/353179 [patent_app_country] => US [patent_app_date] => 2012-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 24311 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13353179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9455213 [patent_doc_number] => 08716221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-06 [patent_title] => 'Modified exendins and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/334912 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 12385 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227312 [patent_doc_number] => 08632979 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'Methods for determining agents that treat or prevent obesity and/or obesity related diseases and methods for treatment therewith' [patent_app_type] => utility [patent_app_number] => 13/298370 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 6600 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239196 [patent_doc_number] => 08603987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Monoclonal antibodies to fibroblast growth factor receptor 2' [patent_app_type] => utility [patent_app_number] => 13/284838 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12733 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13284838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710826 [patent_doc_number] => 08835394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Treatment for basal cell carcinoma' [patent_app_type] => utility [patent_app_number] => 13/276068 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4921 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056619 [patent_doc_number] => 20120078028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/249111 [patent_app_country] => US [patent_app_date] => 2011-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 40583 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20120078028.pdf [firstpage_image] =>[orig_patent_app_number] => 13249111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720257 [patent_doc_number] => 20120009592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'ENPP1 (PC-1) GENE HAPLOTYPE ASSOCIATED WITH THE RISK OF OBESITY AND TYPE 2 DIABETES AND THEIR APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/197327 [patent_app_country] => US [patent_app_date] => 2011-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16047 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009592.pdf [firstpage_image] =>[orig_patent_app_number] => 13197327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9468411 [patent_doc_number] => 08722041 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Anti-human equilibrative nucleoside transporter 1 (hENT1) antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/161941 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14356 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669085 [patent_doc_number] => 20110318354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'CYTOKINE RECEPTOR ZCYTOR17 MULTIMERS' [patent_app_type] => utility [patent_app_number] => 13/085645 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 85852 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760264 [patent_doc_number] => 08420785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Soluble human ST-2 antibodies and assays' [patent_app_type] => utility [patent_app_number] => 13/083333 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 22704 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13083333 [rel_patent_id] =>[rel_patent_doc_number] =>)